UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...

Differential Potential of Pharmacological PARP Inhibitors for Inhibiting Cell Proliferation and Inducing Apoptosis in Human Breast Cancer Cells

Journal of cellular biochemistry, 2015-12, Vol.116 (12), p.2824-2839

2015

Link zum Volltext

Verfügbarkeit prüfen

PARP inhibition potentiates the cytotoxic activity of C-1305, a selective inhibitor of topoisomerase II, in human BRCA1-positive breast cancer cells

Biochemical pharmacology, 2012-11, Vol.84 (10), p.1318-1331

2012

Link zum Volltext

Verfügbarkeit prüfen

Rapid onset of nucleolar disintegration preceding cell cycle arrest in roscovitine‐induced apoptosis of human MCF‐7 breast cancer cells

International journal of cancer, 2003-09, Vol.106 (4), p.486-495

2003

Link zum Volltext

Verfügbarkeit prüfen

Increased susceptibility of poly(ADP-ribose) polymerase-1 knockout cells to antitumor triazoloacridone C-1305 is associated with permanent G2 cell cycle arrest

Cancer research (Chicago, Ill.), 2004-07, Vol.64 (13), p.4487-4497

2004

Link zum Volltext

Verfügbarkeit prüfen

Escape of p53 protein from E6‐mediated degradation in HeLa cells after cisplatin therapy

International journal of cancer, 2002-09, Vol.101 (2), p.128-136

2002

Link zum Volltext

Verfügbarkeit prüfen

In vivo activated caspase-3 cleaves PARP-1 in rat liver after administration of the hepatocarcinogen N-nitrosomorpholine (NNM) generating the 85 kDa fragment

Journal of cellular biochemistry, 2004-11, Vol.93 (4), p.774-787

2004

Link zum Volltext

Verfügbarkeit prüfen

How the Nucleolar Sequestration of p53 Protein or Its Interplayers Contributes to Its (Re)-Activation

Annals of the New York Academy of Sciences, 2003-12, Vol.1010 (1), p.266-272

2003

Link zum Volltext

Verfügbarkeit prüfen

Phenol red in the culture medium strongly affects the susceptibility of human MCF-7 cells to roscovitine

Cellular & molecular biology letters, 2007, Vol.12 (2), p.280-293

2007

Link zum Volltext

Verfügbarkeit prüfen

Roscovitine-induced up-regulation of p53AIP1 protein precedes the onset of apoptosis in human MCF-7 breast cancer cells

Molecular cancer therapeutics, 2005-01, Vol.4 (1), p.113-124

2005

Link zum Volltext

Verfügbarkeit prüfen

Non-apoptogenic killing of hela cervical carcinoma cells after short exposure to the alkylating agent N-methyl-N′-nitro-N-nitrosoguanidine (MNNG)

Journal of cellular biochemistry, 2003-08, Vol.89 (6), p.1222-1234

2003

Link zum Volltext

Verfügbarkeit prüfen

Characterization of Autoantibodies against Components of the Nuclear Pore Complexes

Annals of the New York Academy of Sciences, 2007-08, Vol.1109 (1), p.519-530

2007

Link zum Volltext

Verfügbarkeit prüfen

MNNG Induces Dramatic DNA Damage and Non-Apoptotic Changes in Cervical Carcinoma HeLa Cells

Annals of the New York Academy of Sciences, 2003-12, Vol.1010 (1), p.278-282

2003

Link zum Volltext

Verfügbarkeit prüfen

Ribosomal gene transcription is organized in foci within nucleolar components

Histochemistry and cell biology, 1998-02, Vol.109 (2), p.111-118

1998

Link zum Volltext

Verfügbarkeit prüfen

Whether to target single or multiple CDKs for therapy? That is the question

Journal of cellular physiology, 2011-02, Vol.226 (2), p.341-349

2011

Link zum Volltext

Verfügbarkeit prüfen

Roscovitine, a selective CDK inhibitor, reduces the basal and estrogen-induced phosphorylation of ER-α in human ER-positive breast cancer cells

Journal of cellular biochemistry, 2011-03, Vol.112 (3), p.761-772

2011

Link zum Volltext

Verfügbarkeit prüfen

Targeting p53 as a promising therapeutic option for cancer by re-activating the wt or mutant p53's tumor suppression

Future medicinal chemistry, 2018-04, Vol.10 (7), p.755

Węsierska-Gądek, Józefa

2018

Link zum Volltext

Verfügbarkeit prüfen

Nuclear Ras: Unexpected subcellular distribution of oncogenic forms

Journal of cellular biochemistry, 2001, Vol.81 (S36), p.1-11

2001

Link zum Volltext

Verfügbarkeit prüfen

Differential susceptibility of normal and PARP knock-out mouse fibroblasts to proteasome inhibitors

Journal of cellular biochemistry, 2000-09, Vol.78 (4), p.681-696

2000

Link zum Volltext

Verfügbarkeit prüfen

Roscovitine-activated HIP2 kinase induces phosphorylation of wt p53 at Ser-46 in human MCF-7 breast cancer cells

Journal of cellular biochemistry, 2007-03, Vol.100 (4), p.865-874

2007

Link zum Volltext

Verfügbarkeit prüfen

Outcome of treatment of human HeLa cervical cancer cells with roscovitine strongly depends on the dosage and cell cycle status prior to the treatment

Journal of cellular biochemistry, 2009-04, Vol.106 (5), p.937-955

2009

Link zum Volltext

Verfügbarkeit prüfen

Selective cyclin-dependent kinase inhibitors discriminating between cell cycle and transcriptional kinases: future reality or utopia?

Annals of the New York Academy of Sciences, 2009-08, Vol.1171 (1), p.228-241

2009

Link zum Volltext

Verfügbarkeit prüfen

Roscovitine Differentially Affects Asynchronously Growing and Synchronized Human MCF-7 Breast Cancer Cells

Annals of the New York Academy of Sciences, 2009-08, Vol.1171 (1), p.250-256

2009

Link zum Volltext

Verfügbarkeit prüfen

Monitoring of Long-Term Effects of Resveratrol on Cell Cycle Progression of Human HeLa Cells after Administration of a Single Dose

Annals of the New York Academy of Sciences, 2009-08, Vol.1171 (1), p.257-263

2009

Link zum Volltext

Verfügbarkeit prüfen

Correlation of initial autoantibody profile and clinical outcome in primary biliary cirrhosis

Hepatology (Baltimore, Md.), 2006-05, Vol.43 (5), p.1135-1144

2006

Link zum Volltext

Verfügbarkeit prüfen

Interference with ER-α enhances the therapeutic efficacy of the selective CDK inhibitor roscovitine towards ER-positive breast cancer cells

Journal of cellular biochemistry, 2011-04, Vol.112 (4), p.1103-1117

2011

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 123

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(116)
Mit Volltextzugriff
(101)

Publikationsform

Artikel
(122)
Reviews
(1)

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(92)
Science & Technology
(91)
Life Sciences & Biomedicine
(86)
Cell Biology
(44)
Animals
(40)
Biochemistry & Molecular Biology
(38)
Tumor Suppressor Protein P53 - Metabolism
(33)
Apoptosis
(32)
Cell Cycle - Drug Effects
(30)
Apoptosis - Drug Effects
(29)
Female
(29)
Cyclin-Dependent Kinases - Antagonists & Inhibitors
(27)
Purines - Pharmacology
(26)
Cell Cycle
(24)
Cell Line, Tumor
(24)
Antineoplastic Agents - Pharmacology
(22)
Cell Cycle Arrest
(22)
Biological And Medical Sciences
(21)
Flow Cytometry
(21)
Mice
(20)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Differential Potential of Pharmacological PARP Inhibitors for Inhibiting Cell Proliferation and Inducing Apoptosis in Human Breast Cancer Cells

PARP inhibition potentiates the cytotoxic activity of C-1305, a selective inhibitor of topoisomerase II, in human BRCA1-positive breast cancer cells

Rapid onset of nucleolar disintegration preceding cell cycle arrest in roscovitine‐induced apoptosis of human MCF‐7 breast cancer cells

Increased susceptibility of poly(ADP-ribose) polymerase-1 knockout cells to antitumor triazoloacridone C-1305 is associated with permanent G2 cell cycle arrest

Escape of p53 protein from E6‐mediated degradation in HeLa cells after cisplatin therapy

In vivo activated caspase-3 cleaves PARP-1 in rat liver after administration of the hepatocarcinogen N-nitrosomorpholine (NNM) generating the 85 kDa fragment

How the Nucleolar Sequestration of p53 Protein or Its Interplayers Contributes to Its (Re)-Activation

Phenol red in the culture medium strongly affects the susceptibility of human MCF-7 cells to roscovitine

Roscovitine-induced up-regulation of p53AIP1 protein precedes the onset of apoptosis in human MCF-7 breast cancer cells

Non-apoptogenic killing of hela cervical carcinoma cells after short exposure to the alkylating agent N-methyl-N′-nitro-N-nitrosoguanidine (MNNG)

Characterization of Autoantibodies against Components of the Nuclear Pore Complexes

MNNG Induces Dramatic DNA Damage and Non-Apoptotic Changes in Cervical Carcinoma HeLa Cells

Ribosomal gene transcription is organized in foci within nucleolar components

Whether to target single or multiple CDKs for therapy? That is the question

Roscovitine, a selective CDK inhibitor, reduces the basal and estrogen-induced phosphorylation of ER-α in human ER-positive breast cancer cells

Targeting p53 as a promising therapeutic option for cancer by re-activating the wt or mutant p53's tumor suppression

Nuclear Ras: Unexpected subcellular distribution of oncogenic forms

Differential susceptibility of normal and PARP knock-out mouse fibroblasts to proteasome inhibitors

Roscovitine-activated HIP2 kinase induces phosphorylation of wt p53 at Ser-46 in human MCF-7 breast cancer cells

Outcome of treatment of human HeLa cervical cancer cells with roscovitine strongly depends on the dosage and cell cycle status prior to the treatment

Selective cyclin-dependent kinase inhibitors discriminating between cell cycle and transcriptional kinases: future reality or utopia?

Roscovitine Differentially Affects Asynchronously Growing and Synchronized Human MCF-7 Breast Cancer Cells

Monitoring of Long-Term Effects of Resveratrol on Cell Cycle Progression of Human HeLa Cells after Administration of a Single Dose

Correlation of initial autoantibody profile and clinical outcome in primary biliary cirrhosis

Interference with ER-α enhances the therapeutic efficacy of the selective CDK inhibitor roscovitine towards ER-positive breast cancer cells

Suchergebnisse filtern